首页 | 本学科首页   官方微博 | 高级检索  
     

益生菌发酵豆乳对高脂血症小鼠降血脂及肝损伤缓解的作用
引用本文:张晓磊,武岩峰,朴春红,于寒松,刘俊梅,贾冬梅,华晓曼,王雨珊,王心哲,王玉华.益生菌发酵豆乳对高脂血症小鼠降血脂及肝损伤缓解的作用[J].现代食品科技,2016,32(5):1-8.
作者姓名:张晓磊  武岩峰  朴春红  于寒松  刘俊梅  贾冬梅  华晓曼  王雨珊  王心哲  王玉华
作者单位:(1.吉林农业大学食品科学与工程学院,吉林长春130118),(1.吉林农业大学食品科学与工程学院,吉林长春130118),(1.吉林农业大学食品科学与工程学院,吉林长春130118) (2.国家大豆产业技术体系加工研究室,吉林长春130118),(1.吉林农业大学食品科学与工程学院,吉林长春130118) (2.国家大豆产业技术体系加工研究室,吉林长春130118),(1.吉林农业大学食品科学与工程学院,吉林长春130118) (2.国家大豆产业技术体系加工研究室,吉林长春130118),(1.吉林农业大学食品科学与工程学院,吉林长春130118),(1.吉林农业大学食品科学与工程学院,吉林长春130118),(1.吉林农业大学食品科学与工程学院,吉林长春130118),(1.吉林农业大学食品科学与工程学院,吉林长春130118),(1.吉林农业大学食品科学与工程学院,吉林长春130118) (2.国家大豆产业技术体系加工研究室,吉林长春130118)
基金项目:科技部“十二五”科技支撑计划项目(2013BAD18B07);吉林省教育厅吉林省高校新世纪科学技术优秀人才项目(201439)
摘    要:研究干酪乳杆菌、植物乳杆菌和双歧杆菌在体外降胆固醇能力及三种益生菌混合发酵豆乳对高脂饮食小鼠血脂及肝损伤的影响。采用邻苯二甲醛法评价益生菌体外降胆固醇能力。采用C57BL/6N小鼠,并将其随机分为7组,即对照组;高脂组;干酪乳杆菌发酵豆乳干预组;植物乳杆菌发酵豆乳干预组;双歧杆菌发酵豆乳干预组;三种益生菌混合发酵豆乳干预组;未发酵豆乳干预组。连续喂养7周后,测定血清和肝脏中相关血脂指标,并观察肝脏组织病理学变化。结果表明:干酪乳杆菌、植物乳杆菌和双歧杆菌在体外降胆固醇能力分别为43.14%、46.27%和40.53%。益生菌混合发酵豆乳显著降低小鼠腹部和肾周脂肪指数,血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL),升高高密度脂蛋白(HDL)水平,降低肝脏TC、TG、丙氨酸转氨酶(ALT)和天冬氨酸转氨酶(AST)水平,并明显改善肝脏脂肪堆积。

关 键 词:益生菌  发酵豆乳  高脂血症  肝损伤  降血脂
收稿时间:2015/7/12 0:00:00

Effects of Probiotic-Fermented Soymilk on the Hypolipidemic Activity and on Ameliorating Liver Injury in Hyperlipidemic Mice
ZHANG Xiao-lei,WU Yan-feng,PIAO Chun-hong,YU Han-song,LIU Jun-mei,JIA Dong-mei,HUA Xiao-man,WANG Yu-shan,WANG Xin-zhe and WANG Yu-hua.Effects of Probiotic-Fermented Soymilk on the Hypolipidemic Activity and on Ameliorating Liver Injury in Hyperlipidemic Mice[J].Modern Food Science & Technology,2016,32(5):1-8.
Authors:ZHANG Xiao-lei  WU Yan-feng  PIAO Chun-hong  YU Han-song  LIU Jun-mei  JIA Dong-mei  HUA Xiao-man  WANG Yu-shan  WANG Xin-zhe and WANG Yu-hua
Abstract:The in vitro cholesterol removal ability of Lactobacillus casei, Lactobacillus plantarum, and Bifidobacterium bifidum and the effects of probiotic-fermented soymilk on the blood lipid level and liver injury in mice fed a high-fat diet were investigated. The O-phthalaldehyde method was used to determine the in vitro cholesterol removal ability of probiotics. C57BL/6N mice were randomly divided into seven groups: normal chow group, high-fat group, L. casei-fermented soymilk intervention group, L. plantarum-fermented soymilk intervention group, B. bifidum-fermented soymilk intervention group, probiotic-fermented soymilk intervention group (a mixture of the three types of probiotics), and non-fermented soymilk intervention group. After seven weeks of treatments, the related serum and liver lipid parameters were measured and the histopathological changes in the liver were observed. The in vitro cholesterol removal abilities of L. casei, L. plantarum, and B. bifidum were 43.14%, 46.27%, and 40.53%, respectively. The treatment using the soymilk fermented with the three types of probiotics significantly reduced the abdominal and perirenal fat indexes as well as the serum total cholesterol (TC), triglyceride (TG), and low-density lipoprotein (LDL) levels, while elevating the serum high-density lipoprotein (HDL) level. The liver TC, TG, alanine aminotransferase (ALT), and aspartate aminotransaminase (AST) levels were also reduced. In addition, the accumulation of fat in the liver was improved significantly.
Keywords:probiotics  fermented soymilk  hyperlipidemia  liver injury  hypolipidemic
本文献已被 CNKI 等数据库收录!
点击此处可从《现代食品科技》浏览原始摘要信息
点击此处可从《现代食品科技》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号